
CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 675236-675451
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T86961","span":{"begin":0,"end":215},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"To determine whether rapamycin, a relatively new immunosuppressive agent effective in preventing transplant rejection, is effective treatment for EAN, an animal model for human inflammatory demyelinating neuropathy."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T46","span":{"begin":0,"end":215},"obj":"Sentence"}],"text":"To determine whether rapamycin, a relatively new immunosuppressive agent effective in preventing transplant rejection, is effective treatment for EAN, an animal model for human inflammatory demyelinating neuropathy."}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T1249","span":{"begin":190,"end":203},"obj":"Phenotype"},{"id":"T1250","span":{"begin":204,"end":214},"obj":"Phenotype"}],"attributes":[{"id":"A1249","pred":"hp_id","subj":"T1249","obj":"http://purl.obolibrary.org/obo/HP_0011096"},{"id":"A1250","pred":"hp_id","subj":"T1250","obj":"http://purl.obolibrary.org/obo/HP_0009830"}],"text":"To determine whether rapamycin, a relatively new immunosuppressive agent effective in preventing transplant rejection, is effective treatment for EAN, an animal model for human inflammatory demyelinating neuropathy."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4134","span":{"begin":204,"end":214},"obj":"Disease"},{"id":"T65110","span":{"begin":204,"end":214},"obj":"Disease"}],"attributes":[{"id":"A4134","pred":"mondo_id","subj":"T4134","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"},{"id":"A66545","pred":"mondo_id","subj":"T65110","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"}],"text":"To determine whether rapamycin, a relatively new immunosuppressive agent effective in preventing transplant rejection, is effective treatment for EAN, an animal model for human inflammatory demyelinating neuropathy."}